Contents
Article 6Information exchange on horizontal scientific and technical matters related to joint clinical assessment and joint scientific consultation#
1.The Coordination Group and its subgroups shall ensure an appropriate exchange of information with the European Medicines Agency on horizontal issues of scientific or technical nature related to joint clinical assessment and joint scientific consultation. These exchanges shall occur via the HTA secretariat and shall not relate to the assessment of individual health technologies.
2.The Coordination Group may involve the stakeholder network established pursuant to Article 29 of Regulation (EU) 2021/2282 (‘the HTA stakeholder network’) in the exchange of information referred to in paragraph 1.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.